trovafloxacin has been researched along with Community Acquired Infection in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbon, C; Dunbar, L; Fogarty, C; Hagberg, L; Pullman, J; van Rensburg, DJ | 1 |
| Champlin, J; Pullman, J; Vrooman, PS | 1 |
| Choudhri, S; Church, D; Grossman, C; Haverstock, D; Herman-Gnjidic, Z; Lode, H; McGivern, J | 1 |
| Aguilar, L; Blanquer, R; Caminero, J; Custardoy, J; Dal-Ré, R; Durán, J; García-Méndez, E; García-Rey, C; Gil-Aguado, A; Grau, I; Ibáñez, D; Llorca, E; Martínez, J; Mensa, J; Molinos, L; Moreno, S; Palacios, R; Pallarés, R; Santos, J; Siquier, B; Vidal, J | 1 |
| Daniel, R; de Kock, F; Pluck, N; Trémolières, F | 1 |
| Hopkins, S; Williams, D | 1 |
| Gené, RJ; Luna, CM | 1 |
| Fleurinck, C; Germonpré, PR; Pauwels, RA; Peleman, RA; Rosseel, MT; Van De Velde, V | 1 |
| Cupo, M; File, TM; Garau, J; Schlemmer, B; Young, C | 1 |
| Hammerschlag, MR | 1 |
| Ambler, J; Cardeñosa, O; Lemme, L; Lopez, H; Scarano, S; Smayevsky, J; Stepanik, D; Sucari, A; Vilches, V | 1 |
| Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
| Acampora, MD; Busman, TA; Notario, GF; Sokol, WN; Sullivan, JG | 1 |
1 review(s) available for trovafloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Humans; Ketolides; Macrolides; Naphthyridines; Penicillins; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2003 |
7 trial(s) available for trovafloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Ketolides; Macrolides; Male; Middle Aged; Naphthyridines; Pneumonia, Pneumococcal; Risk Factors; Treatment Outcome | 2003 |
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aza Compounds; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Naphthyridines; Pneumonia, Bacterial; Quinolines; Retrospective Studies; Treatment Outcome | 2003 |
Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 cases.
Topics: Community-Acquired Infections; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Humans; Immunoglobulin G; Legionella; Legionellosis; Naphthyridines; Pneumonia; Treatment Outcome | 2003 |
Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Community-Acquired Infections; Drug Administration Schedule; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Naphthyridines; Penicillins; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
Safety of trovafloxacin in treatment of lower respiratory tract infections.
Topics: Acute Disease; Aged; Anti-Infective Agents; Bronchitis; Cardiovascular System; Chronic Disease; Community-Acquired Infections; Digestive System; Double-Blind Method; Europe; Fluoroquinolones; Humans; Naphthyridines; Nervous System; Pneumonia, Bacterial | 1998 |
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Drug Resistance, Microbial; Female; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumonia, Bacterial | 2001 |
A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; Pneumonia; Prospective Studies; Radiography; Treatment Outcome | 2002 |
6 other study(ies) available for trovafloxacin and Community Acquired Infection
| Article | Year |
|---|---|
[Use of trovafloxacin therapy in community-acquired pneumonia].
Topics: Adult; Aged; Anti-Infective Agents; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Fluoroquinolones; Hospitalization; Humans; Infant; Middle Aged; Naphthyridines; Pneumonia, Bacterial; Risk Factors; Severity of Illness Index | 1999 |
Trovafloxacin concentrations in airway fluids of patients with severe community-acquired pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Bronchi; Bronchoalveolar Lavage Fluid; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Naphthyridines; Pneumonia; Sputum | 2000 |
Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin.
Topics: Anti-Infective Agents; Community-Acquired Infections; Double-Blind Method; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Pneumonia; Randomized Controlled Trials as Topic | 2001 |
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Community-Acquired Infections; Fluoroquinolones; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |